Daniel N Swisher Jr Corcept Therapeutics Inc (CORT) insider trading activity

Daniel N Swisher Jr is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 0 shares of CORT, which is worth approximately $0. The most recent transaction as insider was on May 01, 2024, when has been sold 2,200 shares (Common Stock) at a price of $23.09 per share, resulting in proceeds of $50,798. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Daniel N Swisher Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Open market or private sale	$50,798 $23.09 p/Share	2,200 Reduced 100.0%	0 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Apr 01 2024	SELL Open market or private sale	$55,660 $25.3 p/Share	2,200 Reduced 100.0%	0 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Mar 01 2024	SELL Open market or private sale	$51,898 $23.59 p/Share	2,200 Reduced 100.0%	0 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Feb 01 2024	SELL Open market or private sale	$48,400 $22.0 p/Share	2,200 Reduced 100.0%	0 Common Stock

Feb 01 2024	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Jan 02 2024	SELL Open market or private sale	$48,642 $22.11 p/Share	2,200 Reduced 100.0%	0 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Dec 01 2023	SELL Open market or private sale	$56,034 $25.47 p/Share	2,200 Reduced 100.0%	0 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Nov 01 2023	SELL Open market or private sale	$61,512 $27.96 p/Share	2,200 Reduced 100.0%	0 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Oct 02 2023	SELL Open market or private sale	$60,104 $27.32 p/Share	2,200 Reduced 100.0%	0 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Sep 05 2023	SELL Open market or private sale	$72,380 $32.9 p/Share	2,200 Reduced 100.0%	0 Common Stock
Sep 05 2023	BUY Exercise of conversion of derivative security	$12,892 $5.86 p/Share	2,200 Added 50.0%	2,200 Common Stock
Sep 01 2023	SELL Open market or private sale	$50,731 $32.73 p/Share	1,550 Reduced 100.0%	0 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$10,152 $6.55 p/Share	1,550 Added 50.0%	1,550 Common Stock
Aug 07 2023	SELL Open market or private sale	$85,927 $30.15 p/Share	2,850 Reduced 100.0%	0 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	$17,698 $6.21 p/Share	2,850 Added 50.0%	2,850 Common Stock
Aug 08 2022	SELL Payment of exercise price or tax liability	$131,020 $28.39 p/Share	4,615 Reduced 23.08%	15,385 Common Stock
Aug 08 2022	SELL Open market or private sale	$435,703 $28.32 p/Share	15,385 Reduced 100.0%	0 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$131,000 $6.55 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

CERS

CERUS CORP Healthcare

Director

JAZZ

Jazz Pharmaceuticals plc Healthcare

President and COO

PTGX

Protagonist Therapeutics, Inc Healthcare

Director

DNS